Skip to content
Bookmark Icon
Print Icon
Email Icon

Prostate Cancer

The prostate is a walnut-sized gland that sits below the bladder and in front of the rectum and makes some of the fluid that is part of semen. As men age, their prostates tend to grow — sometimes making it difficult to urinate or causing other serious problems such as prostatitis, benign prostatic hyperplasia, or prostate cancer.

Prostate cancer is a slow growing disease, compared to other cancers. Cancer cells can form in the tissues of the prostate up to 30 years before a tumor is big enough to cause symptoms, according to the National Cancer Institute.

The urologic oncology team at NewYork-Presbyterian provide men with advanced prostate cancer access to the full range of therapies to slow the progression of their disease. Our two cancer centers — the National Cancer Institute–designated Herbert Irving Comprehensive Cancer Center of New York-Presbyterian/Columbia and the NewYork-Presbyterian/Weill Cornell Ronald P. Stanton Clinical Cancer Program — offers patients evidence-based treatments and cutting-edge clinical trials from leaders in the field.

Our Approach to Prostate Cancer Care

Treatment decisions are made based on numerous factors including stage and grade of the disease, your age, your health status, and the possible side effects of treatment. The cancer clinical team at NewYork-Presbyterian — which may include urologic surgeons, pathologists, medical and radiation oncologists, and fertility and sexual health specialists — will discuss with you a range of treatment options that are used one at a time or in combination.

Surveillance. Because prostate cancer is a slow-growing tumor, many men may never need treatment. Instead, our doctors may recommend watchful waiting or active surveillance, in which the patient regularly undergoes prostate-specific antigen (PSA) blood testing or have an annual prostate biopsy. In some cases, monitoring is less intensive — only requiring regular follow-up visits to check for changes in symptoms.

Surgery. If you need surgery for prostate cancer, you may be able to have it robotically, which gives the surgeon an enhanced view of the surgical field and allows for more precise minimally invasive surgery. Our urologic surgeons are experienced in performing the latest prostate cancer procedures, including nerve-sparing prostatectomy and nerve transplant surgery. Your surgical team will tailor a plan of care to meet your needs.

Precision Therapies. Men with early-stage prostate cancer confined to the gland may receive localized treatment that does not require surgery. We use the utmost precision to spare nearby healthy tissues as much as possible and reduce your risk of side effects.

  • Radiation therapy. NewYork-Presbyterian offers image-guided intensity-modulated radiation therapy (IMRT), which aims radiation beams of different intensities from many different angles to precisely treat your tumor. You may be able to have hypo-fractionated radiation therapy, which delivers higher doses of radiation over a shorter total period than conventional radiation therapy (for example, three weeks versus six).
  • Brachytherapy. We also offer brachytherapy — the implantation of tiny radioactive seeds directly into the prostate — which we use to treat localized prostate cancer. We use a new computer-guided technology that permits our radiation oncologists to plan and perform seeding during one procedure.
  • HIFU. We also offer MRI-guided focal therapies for prostate cancer, such high-frequency focused ultrasound (HIFU) — the application of high-energy sound waves to heat and destroy prostate cancer cells.
  • Cryosurgery. Some men can have cryosurgery for prostate cancer — the insertion of needles into the prostate to freeze and destroy the prostate cancer cells. We also perform "salvage" cryotherapy to treat prostate cancers that have continued to grow after radiation therapy.

Next Generation Therapeutic Care through Research

Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine — the research arms of NewYork-Presbyterian — are paving the way for newer treatments to slow the growth of disease and screening methods. Recently, our research physicians and scientists have discovered and developed prostate cancer biomarkers; developed more precise cancer screening tests; and found the link between changes in germ lines of patients with advanced prostate cancer and familial prostate cancer risk. With a $900,000 grant for prostate cancer research from the U.S. Department of Defense (DoD), NewYork-Presbyterian, Weill Cornell Medicine, and Columbia University Irving Medical Center is expanding our already robust portfolio of clinical trials. That means our patients have access to groundbreaking therapies such as molecular imaging to visualize and treat prostate cancer that has metastasized. To learn more about our clinical trials and research programs, visit our clinical trials page.

Appointments & Referrals

NewYork-Presbyterian has been New York’s No. 1 hospital for 18 consecutive years for a simple reason — we put patients first. It is easier now than ever before to receive high-quality care from a leader in health care.

Refer a patient

At NewYork-Presbyterian, we treat a diverse patient population with urologic cancers, including bladder, kidney, penile, prostate, and testicular tumors. Clinicians in private practice or at other hospitals are welcome to refer their patient to NewYork-Presbyterian. Please call 212-305-0114 to refer a patient to the Herbert Irving Comprehensive Cancer Center or 646-962-9600 to arrange a referral for the Weill Cornell Department of Urology.

Schedule an appointment today

For more information on the comprehensive urologic cancer care available or to schedule your next appointment at NewYork-Presbyterian, please call:

Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/ Columbia

622 West 168 St.
Floor 18
New York, NY 10032
212-305-0114

Department of Urology
NewYork-Presbyterian Hospital/Weill Cornell

525 East 68 St.
Starr 900
New York, NY 10065
646-962-9600